valrubicin has been researched along with Carcinoma, Epidermoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, SM; Dagnaes-Hansen, F; Dam, TN; de Darkó, E; Laugesen, IG; Rosada, C; Stenderup, K | 1 |
| Ahmed, A; Hengesteg, A; Israel, M; Koseki, Y; Robbins, KT; Samant, S; Sweatman, TW; Wani, MK; Yarber, RH | 1 |
2 other study(ies) available for valrubicin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Topical application of valrubicin has a beneficial effect on developing skin tumors.
Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Cells, Cultured; Doxorubicin; Humans; Keratinocytes; Keratosis, Actinic; Mice; Papilloma; Skin; Skin Neoplasms | 2010 |
Rationale for intralesional valrubicin in chemoradiation of squamous cell carcinoma of the head and neck.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Cricetinae; Doxorubicin; Head and Neck Neoplasms; Injections, Intralesional; Models, Animal; Tumor Cells, Cultured | 2000 |